SI1765337T1 - Kombinacija tenofovirja, ritonavirja in TMC114 - Google Patents

Kombinacija tenofovirja, ritonavirja in TMC114

Info

Publication number
SI1765337T1
SI1765337T1 SI200530488T SI200530488T SI1765337T1 SI 1765337 T1 SI1765337 T1 SI 1765337T1 SI 200530488 T SI200530488 T SI 200530488T SI 200530488 T SI200530488 T SI 200530488T SI 1765337 T1 SI1765337 T1 SI 1765337T1
Authority
SI
Slovenia
Prior art keywords
tenofovir
ritonavir
combination
tmc114
hiv
Prior art date
Application number
SI200530488T
Other languages
English (en)
Inventor
Richard Marinus Wilhelmus Hoetelmans
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of SI1765337T1 publication Critical patent/SI1765337T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200530488T 2004-07-08 2005-07-08 Kombinacija tenofovirja, ritonavirja in TMC114 SI1765337T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103256 2004-07-08
EP05774136A EP1765337B1 (en) 2004-07-08 2005-07-08 Combination of tenofovir, ritonavir and tmc114

Publications (1)

Publication Number Publication Date
SI1765337T1 true SI1765337T1 (sl) 2009-02-28

Family

ID=34929311

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530488T SI1765337T1 (sl) 2004-07-08 2005-07-08 Kombinacija tenofovirja, ritonavirja in TMC114

Country Status (19)

Country Link
US (1) US20070208009A1 (sl)
EP (1) EP1765337B1 (sl)
JP (1) JP2008505870A (sl)
CN (1) CN1984654A (sl)
AT (1) ATE406161T1 (sl)
AU (1) AU2005261701A1 (sl)
BR (1) BRPI0513051A (sl)
CA (1) CA2572551A1 (sl)
DE (1) DE602005009366D1 (sl)
DK (1) DK1765337T3 (sl)
ES (1) ES2313394T3 (sl)
HR (1) HRP20080612T3 (sl)
MX (1) MXPA06014930A (sl)
NZ (1) NZ551841A (sl)
PL (1) PL1765337T3 (sl)
RU (1) RU2368380C2 (sl)
SI (1) SI1765337T1 (sl)
WO (1) WO2006005720A1 (sl)
ZA (1) ZA200700176B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055455A1 (en) * 2004-11-16 2006-05-26 Boehringer Ingelheim International, Gmbh Method for treating hiv infection through co-administration of tipranavir and darunavir
EP2214668A1 (en) * 2007-10-29 2010-08-11 Cipla Limited Novel antiretroviral combination
PA8809601A1 (es) 2007-12-24 2009-07-23 Cipla Ltd Combinación anti-retroviral
CN102876714A (zh) * 2011-09-07 2013-01-16 深圳市易瑞生物技术有限公司 用慢病毒检测hiv耐药表型
WO2013057469A1 (en) * 2011-10-20 2013-04-25 Cipla Limited Pharmaceutical antiretroviral compositions
RU2648457C2 (ru) * 2012-10-23 2018-03-26 Сипла Лимитед Фармацевтическая антиретровирусная композиция
WO2014184553A1 (en) * 2013-05-15 2014-11-20 Cipla Limited Pharmaceutical antiretroviral compositions
WO2015028875A2 (en) * 2013-08-29 2015-03-05 Teva Pharmaceuticals Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
WO2015155673A1 (en) * 2014-04-08 2015-10-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
US10213507B2 (en) * 2017-03-10 2019-02-26 The Florida International University Board Of Trustees Compositions and methods for treating HIV-associated neurocognitive disorders
RU2662160C9 (ru) * 2017-07-03 2018-10-22 Александрович Иващенко Андрей Комбинированный лекарственный препарат для терапии вирусных инфекций

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors

Also Published As

Publication number Publication date
NZ551841A (en) 2009-04-30
RU2007104774A (ru) 2008-08-20
JP2008505870A (ja) 2008-02-28
WO2006005720A1 (en) 2006-01-19
DK1765337T3 (da) 2009-01-05
US20070208009A1 (en) 2007-09-06
HRP20080612T3 (en) 2009-01-31
CN1984654A (zh) 2007-06-20
EP1765337B1 (en) 2008-08-27
EP1765337A1 (en) 2007-03-28
DE602005009366D1 (de) 2008-10-09
ZA200700176B (en) 2008-04-30
AU2005261701A1 (en) 2006-01-19
ATE406161T1 (de) 2008-09-15
CA2572551A1 (en) 2006-01-19
ES2313394T3 (es) 2009-03-01
RU2368380C2 (ru) 2009-09-27
BRPI0513051A (pt) 2008-04-22
PL1765337T3 (pl) 2009-02-27
MXPA06014930A (es) 2007-02-28

Similar Documents

Publication Publication Date Title
HRP20080612T3 (en) Combination of tenofovir, ritonavir and tmc114
HUS1700003I1 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
MXPA05002814A (es) Formulacion para agentes lipofilicos.
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
TR200101103T2 (tr) CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar
MY144318A (en) Methods of treating hiv infection.
NO20045323L (no) Antistoffer
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
HUP0300590A2 (hu) Peptidázzal hasítható, célzott antineoplasztikus szerek és terápiás alkalmazásuk
WO2006034001A3 (en) Methods of treating hiv infection
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
IS8051A (is) Kladríbínefnablöndur til inngjafar um munn
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
PT971717E (pt) Amino-acucar citotoxico e derivados de acucar afins de indolopirrolocarbazois
WO2004041158A3 (en) Rifalazil compositions and therapeutic regimens
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
AP2001002369A0 (en) Pharmaceutical complex.
NO983437D0 (no) Administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
ECSP024344A (es) Composiciones farmaceuticas